2020 Q2 Form 10-Q Financial Statement
#000119312520220348 Filed on August 14, 2020
Income Statement
Concept | 2020 Q2 |
---|---|
Revenue | $17.88M |
YoY Change | |
Cost Of Revenue | $5.570M |
YoY Change | |
Gross Profit | $12.31M |
YoY Change | |
Gross Profit Margin | 68.84% |
Selling, General & Admin | $9.789M |
YoY Change | |
% of Gross Profit | 79.54% |
Research & Development | $2.400M |
YoY Change | |
% of Gross Profit | 19.5% |
Depreciation & Amortization | $20.00K |
YoY Change | |
% of Gross Profit | 0.16% |
Operating Expenses | $12.95M |
YoY Change | |
Operating Profit | -$641.0K |
YoY Change | |
Interest Expense | $27.56K |
YoY Change | |
% of Operating Profit | |
Other Income/Expense, Net | |
YoY Change | |
Pretax Income | -$640.0K |
YoY Change | |
Income Tax | $6.000K |
% Of Pretax Income | |
Net Earnings | -$646.0K |
YoY Change | |
Net Earnings / Revenue | -3.61% |
Basic Earnings Per Share | |
Diluted Earnings Per Share | -$683.90 |
COMMON SHARES | |
Basic Shares Outstanding | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2020 Q2 |
---|---|
SHORT-TERM ASSETS | |
Cash & Short-Term Investments | $1.505M |
YoY Change | |
Cash & Equivalents | $32.02M |
Short-Term Investments | |
Other Short-Term Assets | $174.5K |
YoY Change | |
Inventory | |
Prepaid Expenses | $174.5K |
Receivables | |
Other Receivables | |
Total Short-Term Assets | $1.680M |
YoY Change | |
LONG-TERM ASSETS | |
Property, Plant & Equipment | |
YoY Change | |
Goodwill | |
YoY Change | |
Intangibles | |
YoY Change | |
Long-Term Investments | $414.0M |
YoY Change | |
Other Assets | |
YoY Change | |
Total Long-Term Assets | $414.0M |
YoY Change | |
TOTAL ASSETS | |
Total Short-Term Assets | $1.680M |
Total Long-Term Assets | $414.0M |
Total Assets | $415.7M |
YoY Change | |
SHORT-TERM LIABILITIES | |
YoY Change | |
Accounts Payable | |
YoY Change | |
Accrued Expenses | $76.67K |
YoY Change | |
Deferred Revenue | |
YoY Change | |
Short-Term Debt | $0.00 |
YoY Change | |
Long-Term Debt Due | |
YoY Change | |
Total Short-Term Liabilities | $301.7K |
YoY Change | |
LONG-TERM LIABILITIES | |
Long-Term Debt | $0.00 |
YoY Change | |
Other Long-Term Liabilities | $14.49M |
YoY Change | |
Total Long-Term Liabilities | $14.49M |
YoY Change | |
TOTAL LIABILITIES | |
Total Short-Term Liabilities | $301.7K |
Total Long-Term Liabilities | $14.49M |
Total Liabilities | $14.79M |
YoY Change | |
SHAREHOLDERS EQUITY | |
Retained Earnings | -$36.39K |
YoY Change | |
Common Stock | |
YoY Change | |
Preferred Stock | |
YoY Change | |
Treasury Stock (at cost) | |
YoY Change | |
Treasury Stock Shares | |
Shareholders Equity | -$87.35M |
YoY Change | |
Total Liabilities & Shareholders Equity | $415.7M |
YoY Change |
Cashflow Statement
Concept | 2020 Q2 |
---|---|
OPERATING ACTIVITIES | |
Net Income | -$646.0K |
YoY Change | |
Depreciation, Depletion And Amortization | $20.00K |
YoY Change | |
Cash From Operating Activities | -$159.7K |
YoY Change | |
INVESTING ACTIVITIES | |
Capital Expenditures | $10.00K |
YoY Change | |
Acquisitions | |
YoY Change | |
Other Investing Activities | -$414.0M |
YoY Change | |
Cash From Investing Activities | -$414.0M |
YoY Change | |
FINANCING ACTIVITIES | |
Cash Dividend Paid | |
YoY Change | |
Common Stock Issuance & Retirement, Net | |
YoY Change | |
Debt Paid & Issued, Net | |
YoY Change | |
Cash From Financing Activities | 415.7M |
YoY Change | |
NET CHANGE | |
Cash From Operating Activities | -159.7K |
Cash From Investing Activities | -414.0M |
Cash From Financing Activities | 415.7M |
Net Change In Cash | 1.505M |
YoY Change | |
FREE CASH FLOW | |
Cash From Operating Activities | -$159.7K |
Capital Expenditures | $10.00K |
Free Cash Flow | -$169.7K |
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2020Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2020Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1505028 | |
CY2020Q2 | us-gaap |
Assets Current
AssetsCurrent
|
1679536 | |
CY2020Q2 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
414027563 | |
CY2020Q2 | us-gaap |
Assets
Assets
|
415707099 | |
CY2020Q2 | us-gaap |
Liabilities
Liabilities
|
14791666 | |
CY2020Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
5035172 | |
CY2020Q2 | heccu |
Accrued Offering Costs
AccruedOfferingCosts
|
225000 | |
CY2020Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
301666 | |
CY2020Q2 | heccu |
Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
|
14490000 | |
CY2020Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-36385 | |
CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5000003 | |
CY2020Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
415707099 | |
CY2020Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2020Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
||
CY2020Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
||
CY2020Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
62948 | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
63948 | ||
CY2020Q2 | heccu |
Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
|
27563 | |
heccu |
Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
|
27563 | ||
CY2020Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-35385 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-36385 | ||
heccu |
Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
|
27563 | ||
heccu |
Formation Costs Paid By Sponsor
FormationCostsPaidBySponsor
|
-2125 | ||
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
174508 | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
76666 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-159665 | ||
us-gaap |
Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
|
414000000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-414000000 | ||
us-gaap |
Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
|
405720000 | ||
us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
10280000 | ||
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
129606 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
415664693 | ||
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1505028 | ||
heccu |
Initial Classification Of Common Stock Subject To Possible Redemption
InitialClassificationOfCommonStockSubjectToPossibleRedemption
|
395946830 | ||
heccu |
Deferred Underwriting Fee Payables
DeferredUnderwritingFeePayables
|
14490000 | ||
heccu |
Deferred Offering Costs Paid Directly By Sponsor
DeferredOfferingCostsPaidDirectlyBySponsor
|
25000 | ||
CY2020Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
10280000 | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div><div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
CY2020Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
76666 | |
CY2020Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-62948 | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-63948 | ||
CY2020Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-35385 | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-36385 | ||
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
205701 | ||
heccu |
Shares Subject To Possible Redemption Amount
SharesSubjectToPossibleRedemptionAmount
|
-31400 | ||
heccu |
Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
|
225000 | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2020-06-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2020 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
CY2020Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
174508 | |
us-gaap |
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
127481 | ||
us-gaap |
Payments For Underwriting Expense
PaymentsForUnderwritingExpense
|
8280000 | ||
heccu |
Under Writing Deferred Fee Per Unit
UnderWritingDeferredFeePerUnit
|
0.35 | ||
CY2020Q2 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
41400000 | |
CY2020Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
CY2020Q2 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
39591543 | |
CY2020Q2 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
7600 | |
CY2020Q2 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.00 | |
CY2020Q2 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
7600 | |
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.00 | ||
CY2020Q2 | heccu |
Franchise And Income Tax Expense
FranchiseAndIncomeTaxExpense
|
27000 | |
heccu |
Franchise And Income Tax Expense
FranchiseAndIncomeTaxExpense
|
27000 | ||
CY2020Q2 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | |
CY2020Q2 | heccu |
Other Offering Costs
OtherOfferingCosts
|
583182 | |
CY2020Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
11.50 | |
CY2020Q2 | us-gaap |
Cash
Cash
|
1505028 | |
CY2020Q2 | us-gaap |
Assets Held In Trust
AssetsHeldInTrust
|
414000000 | |
CY2020Q2 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
10.00 | |
CY2020Q2 | us-gaap |
Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
|
10.00 | |
CY2020Q2 | heccu |
Minimum Tangible Assets For Business Combination
MinimumTangibleAssetsForBusinessCombination
|
5000001 | |
CY2020Q2 | heccu |
Interest To Pay Dissolution Expenses
InterestToPayDissolutionExpenses
|
100000 | |
CY2020Q2 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
10.00 | |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
0 | ||
heccu |
Under Writing Discount Per Unit Cash Paid
UnderWritingDiscountPerUnitCashPaid
|
0.20 | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Shell Company
EntityShellCompany
|
true | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
Hudson Executive Investment Corp. | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001803901 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
CY2020Q1 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
25000 | |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1000 | |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
24000 | |
CY2020Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
390646818 | |
CY2020Q2 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
10280000 | |
CY2020Q2 | us-gaap |
Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
|
395915430 |